Antimotility agents and E. coli infection.
作者信息
Tarr P I, Christie D L
出版信息
CMAJ. 1999 Apr 6;160(7):984, 986.
Abstract
摘要
相似文献
1
Antimotility agents and E. coli infection.
CMAJ. 1999 Apr 6;160(7):984, 986.
2
Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
N Engl J Med. 2000 Oct 26;343(17):1271; author reply 1272-3.
3
E. coli, antibiotics and hemolytic-uremic syndrome in children.
CMAJ. 2000 Aug 22;163(4):438.
4
E. coli, antibiotics, and the hemolytic-uremic syndrome.
N Engl J Med. 2000 Jun 29;342(26):1990-1. doi: 10.1056/NEJM200006293422611.
5
Escherichia coli infections and hemolytic-uremic syndrome.
CMAJ. 2001 May 15;164(10):1406.
6
Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
N Engl J Med. 2000 Oct 26;343(17):1271-2; author reply 1272-3. doi: 10.1056/NEJM200010263431716.
7
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
8
Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites.
Clin Infect Dis. 2011 May;52(9):1130-2. doi: 10.1093/cid/cir087.
9
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
N Engl J Med. 2000 Jun 29;342(26):1930-6. doi: 10.1056/NEJM200006293422601.
10
Escherichia coli infections and hemolytic-uremic syndrome.
CMAJ. 2001 May 15;164(10):1405-6.
引用本文的文献
1
Enterohemorrhagic (EHEC)-Secreted Serine Protease EspP Stimulates Electrogenic Ion Transport in Human Colonoid Monolayers.
Toxins (Basel). 2018 Sep 1;10(9):351. doi: 10.3390/toxins10090351.
2
Travellers' diarrhea in children.
Paediatr Child Health. 2003 Feb;8(2):99-103. doi: 10.1093/pch/8.2.99.
Zotero 插件